InterVenn

formerly InterVenn BioSciences

InterVenn Biosciences | Clinical Glycoproteomics

South San Francisco, United States · Founded 2017 · $253.8M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$253.8M
Last Round
$201.0M Series CAug 2021
Rounds
4

About

InterVenn Biosciences pioneers AI- and ML-powered glycoproteomic analysis through its GlycoVision platform, enabling high-throughput biomarker discovery from blood samples. Co-founded in 2017 by Nobel Laureate Carolyn Bertozzi, Dr. Carlito Lebrilla, and Aldo Carrascoso, the company serves biopharma partners and clinicians with diagnostic applications including GlycoKnow Ovarian for ovarian cancer detection.

Summary

InterVenn is an Artificial Intelligence company based in South San Francisco, United States, founded in 2017. It has raised $253.8M in total across 4 rounds, most recently a $201.0M Series C round in Aug 2021. Investors include Amplify Partners, Genoa Ventures and Anzu Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CAug 2021
$201.0M

Sign up to see all 4 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

InterVenn on Indexed.vc
<a href="https://indexed.vc/companies/intervenn"><img src="https://indexed.vc/api/badge/company/intervenn" alt="InterVenn on Indexed.vc" width="260" height="76" /></a>